CVR 38603248Private limited company (ApS)Dyrlæger (750000)HolbækFounded 27 Apr 2017
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about AniCura Holbæk Dyrehospital ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
18
CVR, 2022
Gross profit
9.5M
DKK, annual report 2021
+0.5% on 2020
Result
+1.7M
DKK, annual report 2021
Equity
13M
DKK, annual report 2021
ANICURA ApSCVR 34897778, 100% of capital and votes, until 7 Nov 2022
Flemming Terpager Samsøe-Schmidtuntil 7 Nov 2022
No current owner is registered.
50% to under 66.7% of capital and votes27 Apr 2017 to 22 Jul 2017
50% to under 66.7% of capital and votes27 Apr 2017 to 22 Jul 2017
CVR 34897778100% of capital and votesnotified 30 Jun 20206 Dec 2018 to 7 Nov 2022
CVR 3880660220% to under 25% of capital and votesnotified 30 Jun 20209 May 2017 to 30 Jun 2020
CVR 3880659920% to under 25% of capital and votesnotified 30 Jun 20209 May 2017 to 30 Jun 2020
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
Founded 27 Apr 2017.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Oct 2022, monthly: 18 employees, 13 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 16 | 19 | 17 | 17 | 18 | 18 | 19 | 17 | 17 | 17 | 17 | 16 | 16 | 15 | 15 | 15 | 15 | 16 | 15 | 14 | 16 | 15 | 15 | 16 | 15 | 17 | 17 | 17 | 16 | 15 | 15 | 16 | 16 | 15 | 14 | 16 | 15 | 16 | 16 | 17 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 | 16 | 16 | 17 | 16 | 16 | 16 | 14 | 16 | 16 | 16 | 16 | 18 | 18 | 18 | 17 | 18 | 18 |
| FTE | 11 | 15 | 11 | 11 | 12 | 12 | 12 | 11 | 10 | 11 | 11 | 10 | 11 | 10 | 10 | 10 | 9 | 10 | 9 | 9 | 10 | 9 | 9 | 10 | 10 | 10 | 12 | 10 | 9 | 10 | 11 | 10 | 12 | 11 | 13 | 13 | 12 | 12 | 13 | 11 | 11 | 12 | 12 | 12 | 13 | 11 | 13 | 15 | 12 | 12 | 14 | 13 | 14 | 12 | 12 | 13 | 12 | 11 | 14 | 15 | 14 | 13 | 11 | 13 | 13 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Oct 2022, published 21 Dec 2022.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2021, DKK: Gross profit 9.5M, Operating profit 2.2M, Result for the year 1.7M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2021, DKK: Total assets 15.8M, Equity 13M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Gross profit | 7,173 | 7,517 | 8,279 | 9,497 | 9,541 |
| Operating profit | +105 | +1,619 | +1,702 | +2,530 | +2,171 |
| Result for the year | +68 | +1,201 | +1,379 | +2,094 | +1,691 |
| Equity | 4,345 | 7,817 | 9,196 | 11,289 | 12,980 |
| Total assets | 6,586 | 11,107 | 12,054 | 15,038 | 15,799 |
| Employees (average) | 13 | Not reported | 12 | 12 | 12 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | 4.8% | 8.9% | 14.7% | 0.5% |
| EBITDA | 638 | 2,158 | 2,313 | 3,069 | 2,746 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | Not reportednote 2 | 0% | 0% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 3 | 275note 4 | 161note 4 | 287note 4 | 186note 4 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for AniCura Holbæk Dyrehospital ApS:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 5,020,754, cash price 96.48, implied value 9,844,599 | 96.48 | 5,020,754 | 9,844,599 | 102,041 | |
| DecreaseMoved to a reserve | None | None | None | 50,000 | |
| FoundingAn existing businessPaid in 8,167,000 | None | 8,167,000 | None | 100,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Merger (fusion), as the ceasing company (ophørende selskab)
Demerger (spaltning), as the demerged company (indskydende selskab)
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
11 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en fusionsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende selskaber må antages at være tilstrækkeligt sikrede efter fusionen.
Virksomheden er d. 07.11.2022 opløst ved fusion med CVR-nummer: 34897778 ANICURA ApS.
Bestyrelse:
Fratrådte:
Flemming Terpager Samsøe-Schmidt, den 14.09.2022.
Tiltrådte:
Caroline Helle Møller, den 14.09.2022.
Direktion:
Fratrådte:
Jesper Vetter, den 10.08.2022.
Vedtægter ændret: 19.10.2021
Bestyrelse:
Fratrådte:
Jesper Vetter, den 19.10.2021, Malin de Maré, (næstformand), den 19.10.2021.
Tiltrådte:
Morten Gerner, (næstformand), den 19.10.2021, Flemming Terpager Samsøe-Schmidt, den 19.10.2021.
Direktion:
Fratrådte:
Flemming Terpager Samsøe-Schmidt, den 19.10.2021.
Tiltrådte:
Flemming Terpager Samsøe-Schmidt, (adm. dir), den 19.10.2021.
Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller 1 bestyrelsesmedlem i forening med 1 direktør eller af den samlede bestyrelse.
Vedtægter ændret: 30.06.2020
Bestyrelse:
Fratrådte:
Ann Jensen, den 30.06.2020.
Tiltrådte:
Malin de Maré, (næstformand), den 30.06.2020.
Selskabet tegnes af en direktør i forening med formanden for bestyrelsen, en direktør i forening med næstformanden for bestyrelsen eller af to bestyrelsesmedlemmer i forening
Bestyrelse:
Fratrådte:
Mette Erbs, den 01.11.2019, Peter Thomsen, (formand), den 01.11.2019.
Tiltrådte:
Tanja Sølvkjær Frandsen, (formand), den 01.11.2019, Ann Jensen, den 01.11.2019.
Revision:
Fratrådte:
REVISION KØBENHAVN GODKENDT REVISIONSPARTNERSELSKAB, den 01.11.2019.
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 01.11.2019.
Vedtægter ændret: 06.12.2018
Nyt navn: AniCura Holbæk Dyrehospital ApS
Kapitalforhøjelsen er besluttet den 06.12.2018.
kr. 52.041,00, indbetalt kontant, kurs 9.647,69.
Kapitalen udgør herefter kr. 102.041,00.
Bestyrelse:
Tiltrådte:
Mette Erbs, den 06.12.2018, Peter Thomsen, (formand), den 06.12.2018, Jesper Vetter, den 06.12.2018.
Selskabet tegnes af bestyrelsesformanden eller af en direktør..
Vedtægter ændret: 20.02.2018
Kapitalnedsættelse besluttet 19.02.2018 er gennemført 03.04.2018.
Kapitalen udgør herefter kr. 50.000,00.
Vedtægter ændret: 19.02.2018
Kapitalnedsættelse besluttet 19.02.2018 henlæggelse til særlig reserve kr. 50.000,00 til kurs 100,00.
Virksomhedens kreditorer opfordres til at indberette deres krav til virksomheden. Kreditorerne kan kræve betryggende sikkerhed for uforfaldne krav og betaling af forfaldne krav. Krav skal indberettes senest 4 uger fra dags dato.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående spaltning. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en spaltningsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende virksomheder må antages at være tilstrækkeligt sikrede efter spaltningen.
Aktiver og gæld er overdraget til CVR-nummer 39065975 LCW 2017 ApS.
Stiftelsesdato: 27.04.2017.
Virkningsdato: 27.04.2017.
Seneste vedtægtsdato: 27.04.2017.
Kapital:
kr. 100.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt ved indskud af bestående virksomhed kr. 100.000,00 til kurs 8.167,00, fuldt indbetalt.
Stiftere:
Flemming Samsøe-Schmidt, den 27.04.2017, Jesper Vetter, den 27.04.2017.
Direktion:
Flemming Terpager Samsøe-Schmidt, den 27.04.2017, Jesper Vetter, den 27.04.2017.
Virksomheden tegnes af direktionen..
Revision:
CVR-NR. 34619654 REVISION KØBENHAVN GODKENDT REVISIONSPARTNERSELSKAB, Nimbusparken 24, 3., 2000 Frederiksberg, den 27.04.2017.
Første regnskabsår:
01.01.2017 - 31.12.2017.
Regnskabsår:
01.01 - 31.12.
Formål:
Virksomhedens formål er at drive dyrehospital og hermed beslægtet virksomhed.